News by Industry

Biotechnology

Releases published in the last 30 days.

Page 1 of 2

European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer
11/20/2009 11:05:10 AM
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that...
Steve DeMorro Named Vice President of Human Resources, Recruitment, and Healthcare Education at Publicis Strategic Solutions Group
11/19/2009 11:20:19 AM
LAWRENCEVILLE, N.J.—November 19, 2009—Publicis Strategic Solutions Group—a leading provider of multichannel message delivery solutions for the life sciences industry—has announced that Steve DeMorro h...
Improving Quality, Cost-Effectiveness, and Time Savings in Preclinical Inhalable Formulation Development
11/18/2009 9:49:07 AM
In today’s fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year’s Drug...
In-solution Method for Streamlining Next-Generation Genome Sequencing Shown to be Uniform, Reproducible across Many Samples
11/18/2009 9:18:54 AM
SANTA CLARA, Calif., Researchers from the Moores University of California San Diego (UCSD) Cancer Center, The Scripps Institute, and Agilent Technologies Inc. (NYSE: A) have shown that "solution enric...
Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
11/18/2009 9:16:13 AM
Abbott Park, Illinois and Waltham, Massachusetts, — Abbott (NYSE: ABT) and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may pl...
Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day
11/18/2009 9:11:54 AM
Brussels, Ingelheim and London - Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have today an...
Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
11/17/2009 10:28:57 AM
* Interim clinical data from approximately 4,000 individuals suggest that half a dose of the currently US-approved Novartis unadjuvanted Influenza A(H1N1) 2009 vaccine met immunogenicity criteria in a...
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
11/16/2009 11:07:21 AM
Upfront and potential consideration of over $500 million London UK, Rockville US - GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) today announced an exclusive worldwide opt...
Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care
11/15/2009 11:23:18 AM
WHITEHOUSE STATION, N.J. - Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a r...
Low Birth Weight and Diabetes Have a Common Genetic Background
11/12/2009 10:43:37 AM
Neuherberg - Low birth weight increases the risk of developing type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it s...
Hebrew University researchers discover mechanism of insulin production that can lead to better treatment for diabetes
11/12/2009 10:40:42 AM
How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universitie...
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
11/12/2009 10:08:01 AM
Anti-NGF Compound Adds to Company’s Early-Stage Pain Care Pipeline Abbott Park, Illinois (NYSE: ABT) — Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV’s...
Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration
11/9/2009 10:03:59 AM
Strategic research collaboration continues for another 4 years at a value of EUR 15 million plus milestones and royalties Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT; TecDAX, NASDA...
Scientists at TU Braunschweig and DeveloGen AG receive Phoenix Science Award 2009 for a publication in the field of beta cell regeneration
11/9/2009 9:53:09 AM
Goettingen, Germany — DeveloGen AG, a biotechnology company focused on the discovery and development of novel therapies for diabetes and other metabolic and endocrine disorders announced today that a ...
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
11/9/2009 9:38:59 AM
London UK - GlaxoSmithKline (GSK) today announced the results from the clinical trial assessing Pandemrix™, GSK’s adjuvanted H1N1 pandemic influenza vaccine, administered at the same time as the annua...
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
11/8/2009 11:53:12 AM
First prequalification for pneumococcal disease vaccine - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day London UK - The World Health Organization (WHO) ...
First report of using radiolabeled antibodies and stem cell transplantation to successfully treat advanced leukemia
11/7/2009 1:07:56 PM
SEATTLE — For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell tra...
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
11/6/2009 10:51:39 AM
New Haven, Conn. — Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells....
A ‘Spectroscopist’s Dream’ Captures the Imagination of Journal Readers
11/4/2009 4:13:07 PM
An article describing structure elucidation methods using NMR achieves status as one of the top 10 most accessed articles in the Journal of Cheminformatics. Toronto, Canada (November 4, 2009) — An...
New Merck Begins Operations
11/4/2009 12:01:59 PM
* With Robust Pipeline, Broader Product Portfolio and Expanded Global Presence WHITEHOUSE STATION, N.J.– Merck & Co., Inc. (NYSE: MRK) today outlined its global plans following the completion of M...